Ranirestat 10mg 10mg | Purity Not Available
Adooq Bioscience
Ranirestat is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy.
More Information Supplier PageSearch Results
CP 31398 2HCl 50mg 50mg | Purity Not Available
Adooq Bioscience
CP 31398 2HCl has been shown to act as a stabilizing agent for p53, and to promotes activity of p53 in cancer cell lines.
More Information Supplier PageCP 31398 2HCl 25mg 25mg | Purity Not Available
Adooq Bioscience
CP 31398 2HCl has been shown to act as a stabilizing agent for p53, and to promotes activity of p53 in cancer cell lines.
More Information Supplier PageCP 31398 2HCl 10mg 10mg | Purity Not Available
Adooq Bioscience
CP 31398 2HCl has been shown to act as a stabilizing agent for p53, and to promotes activity of p53 in cancer cell lines.
More Information Supplier PageCaptopril disulfide 50mg 50mg | Purity Not Available
Adooq Bioscience
Captopril Disulfide is a reversible and competitive inhibitor of LTA4 hydrolase (IC50=11 M). Captopril has been shown to be an of angiotensin converting enzyme-1 (ACE1), but not ACE2(IC50 = 22 nM).
More Information Supplier PageCaptopril disulfide 25mg 25mg | Purity Not Available
Adooq Bioscience
Captopril Disulfide is a reversible and competitive inhibitor of LTA4 hydrolase (IC50=11 M). Captopril has been shown to be an of angiotensin converting enzyme-1 (ACE1), but not ACE2(IC50 = 22 nM).
More Information Supplier PageCaptopril disulfide 10mg 10mg | Purity Not Available
Adooq Bioscience
Captopril Disulfide is a reversible and competitive inhibitor of LTA4 hydrolase (IC50=11 M). Captopril has been shown to be an of angiotensin converting enzyme-1 (ACE1), but not ACE2(IC50 = 22 nM).
More Information Supplier PageNSC 663284 10mg 10mg | Purity Not Available
Adooq Bioscience
NSC 663284 is a potent, cell-permeable, and irreversible inhibitor of all Cdc25 isoforms, with preference for Cdc25A (IC50 = 29, 95, and 89 nM for Cdc25A, Cdc25B2, and Cdc25C, respectively).
More Information Supplier PageNSC 663284 25mg 25mg | Purity Not Available
Adooq Bioscience
NSC 663284 is a potent, cell-permeable, and irreversible inhibitor of all Cdc25 isoforms, with preference for Cdc25A (IC50 = 29, 95, and 89 nM for Cdc25A, Cdc25B2, and Cdc25C, respectively).
More Information Supplier PageBrexpiprazole 10mg 10mg | Purity Not Available
Adooq Bioscience
Brexpiprazole is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).
More Information Supplier Page